• Plant-based food retailer and community builder PlantX Life Inc. is tapping into a growing consumer market focused on health and longevity, providing education and other resources to help make plant-based community goals more accessible
• PlantX Life maintains a digital presence that includes a weekly podcast series, YouTube channel videos, an informative blog and an e-commerce portal accessible through Walmart’s and Amazon’s Marketplace
• The company is preparing to open a store and affiliated website in United States in October and Israel in November to add to its brick-and-mortar presence in Canada     PlantX Life sells over 5,000 products and eventually expects to consistently add new       items and brands to its offerings

One-stop shopping plant community brand builder PlantX Life (CSE: VEGA) (Frankfurt: WNT1) (OTCQB: PLTXF) continues to passionately pursue its mission not only through a growing retail presence, but by establishing an ecosystem that preaches the virtues of plant-based living and the increasingly supportive community arising from common plant lifestyle interests as well. PlantX’s vodcast series provides weekly insights into vegan products, athletes who thrive on a plant-based diet, and industry trends. With season 2 well under way, the “vodcast” recently featured interviews with tennis star Venus Williams and Two Bears co-founder David Schneiderman, whose company sells oat milk lattés, coffee, and oat milk (https://ibn.fm/XvYdC). Through its YouTube channel (https://ibn.fm/56AsQ). PlantX provides upbeat how-to videos for recipes and fitness practices, as well as news about the state of the industry and PlantX’s investor relations. And the company’s blog provides the mortar for binding PlantX’s community of vegan lifestyle interests together with education to make consistency in beneficial habits more accessible (https://ibn.fm/PULUB). “Over the last 10 years I’ve learned that a plant-based diet is a major part of wellness and longevity,” PlantX founder Sean Dollinger said in a video shared this summer about his journey toward a healthier lifestyle. “Don’t feel like you have enough time to prepare healthy food? We’ll deliver plant-based meals right to your door. But it’s not all about food. There are health benefits of having plants in your home and they’re great for home decor and gifts. We also want to help you find the best plant-based restaurants, interact with others in the plant-based community, share ideas and grow together.” As the digital hub of a thriving plant-based market ecosystem, the company sells more than 5,000 plant-based products across North America and anticipates an ongoing expansion of its product lines. In September, PlantX announced a number of initiatives that will expand awareness of its profile. The company will launch as a seller on Amazon Marketplace (https://ibn.fm/Iy9m7) and on Walmart’s Marketplace in the United States after a successful entry on the Walmart Marketplace in Canada (https://ibn.fm/plRwx). The company has already opened a brick-and-mortar store in Squamish, British Columbia, and will open additional physical stores in San Diego in October, and Tel Aviv in November. Additionally, the company will launch an Israel-based website in conjunction with its store there. All of the company’s physical stores will be rebranded as XMarket (https://ibn.fm/wc66z). “We’re here as a resource and hopefully we can give you a healthier and longer life. You can’t put a price tag on that,” Dollinger said. For more information, visit the company’s websites at www.PlantX.com, www.PlantX.ca, and https://investor.plantx.com/ and view PlantX for Plant-Based Investors. NOTE TO INVESTORS: The latest news and updates relating to PLTXF are available in the company’s newsroom at https://ibn.fm/PLTXF

Thursday- October 21, 2021 Venue- Wyndham Grand Hotel, Jupiter, FL The Dawson James Securities’ 6th Annual Small Cap Growth Conference is being held on October 21st 2021 at the scenic Wyndham Grand Hotel, Jupiter, Florida. Small-cap industries, company executives, and investors from the healthcare, technology and consumer sectors are invited to attend this Small Cap Growth Conference. There is no fee for attendees. Since 2004, Dawson James Securities, an investment banking firm with offices in New York, Florida and Maryland has propelled small and microcap public and private growth companies towards growth and lucrative investment opportunities. This 6th annual Small-cap growth conference is focused on providing a unified platform for senior leadership from approximately 40 small-cap growth companies and 12 leading industry sponsors to communicate and develop productive business relationships with institutional funds, family offices and high net-worth investors. The event will feature keynotes and discussions from industry leaders and accredited investors about the trends and the future of investment and growth in the small-cap industries of the healthcare, consumer, and technology segment. 40 participating companies will be  showcased on the 21st with a 2-track presentation format about the nature and prospect of their business and potential benefits of association. Dawson James Securities organizes these conferences for the benefit of small and microcap industries. The format allows potential investors to hear the presenting companies’ stories first hand and to interact directly with senior leadership teams.  This conference specifically targets small and microcap industries that seek exposure and better investment opportunities. Entrepreneurs, startups, and small industries can leverage this conference platform to reach out to investment firms and get discovered by distinguished sponsors to develop long-term networking and business alliances. The event will commence with registration and breakfast promptly at 8:00 a.m. on Thursday, Oct. 21, 2021, followed by corporate presentations, discussions from industry leaders, and one-on-one management meetings. To know more about the event https://ibn.fm/GlnPH.

• Lexaria Bioscience is the global innovator behind the disruptive DehydraTECH(TM) drug delivery technology
• DehydraTECH’s taste-masking capabilities eliminate the need for unwanted sweeteners or chemical masking agents
• The technology also significantly increases the bioavailability of drugs, speeds up the rate of drug onset, and boosts brain absorption
• DehydraTECH presents numerous opportunities and has been evaluated in R&D programs featuring DehydraTECH-processed nicotine, antivirals, and cannabidiol

Oral delivery is the easiest and most convenient way to administer medications, yet it is prevalently associated with patient noncompliance owing to many drugs’ bitter taste. The problem appears widespread and necessitating remedial bitterness-masking interventions. But as recently as 2013 (relative to the mid-19th century origin of the modern pharmaceutical industry), the taste-masking of oral solid dosage forms was still a major challenge that needed to be addressed by formulation or pharmaceutical scientists (https://ibn.fm/7wmaW). The most commonly used taste-masking methods at that time were film coating and the use of sweeteners, sugars, or flavors, but the latter is considered ineffective due to its inability to adequately mask the bitter taste. Still, less conventional methods such as microencapsulation, spray drying, supercritical fluids, and more had already been reported as successful taste-masking techniques. Since then, Lexaria Bioscience (NASDAQ: LEXX), a global innovator whose patented DehydraTECH(TM) drug delivery technology could potentially improve oral administration of Active Pharmaceutical Ingredients (“APIs”), has led the pharmaceutical industry in advancing novel taste-masking techniques. With part of its R&D having progressed from animal studies to human clinical studies, the company has so far established that DehydraTECH masks unwanted taste, thereby eliminating the need for sugar-filled edibles; improves the speed of drug onset; increases the effectiveness of drug delivery into the bloodstream (bioavailability); and boosts brain absorption (https://ibn.fm/la1J9). DehydraTECH’s taste-masking capabilities result from the use of fatty acids. The technology combines the API with fatty acids, such as long-chain fatty acid (“LCFA”), before applying the resultant compound to food/carrier particles (substrate material), performing dehydration synthesis procedure, and, finally, rendering it as powder or liquid for use in desired final form factor. Importantly, according to an evaluation LEXX conducted in collaboration with National Research Council, the largest R&D organization in Canada, DehydraTECH does not alter the chemical structure of the API. The fatty acids offer dual benefits. First, they are believed to block and divert bound APIs away from bitter taste receptors, essentially rendering them flavorless, as well as odorless. “DehydraTECH formulations do not require unwanted sweeteners or chemical masking agents for flavor and odor blocking, allowing manufacturers to create low-sugar products with fewer calories, while also avoiding the use of excessive artificial sweeteners,” reads the company’s website (https://ibn.fm/TfY0x). The LCFA also promotes quick absorption into lymphatics, bypassing the first-pass liver effect, which drastically reduces the bioavailability or overall effectiveness of orally ingested drugs. In this regard and based on findings of clinical testing, DehydraTECH significantly increases bioavailability for fat-soluble drugs. DehydraTECH has so far been evaluated as part of nicotine, antivirals, and cannabinoids (“CBD”) R&D programs. The nicotine program showed that the drug delivery platform significantly increased the quantity of nicotine delivered. It was also responsible for 295% higher brain levels of nicotine compared to controls. Additionally, its first 2021 human clinical study under the CBD program, HYPER-H21-1, has evidenced a rapid and sustained decline in blood pressure, with the reduction being more pronounced in the first 10 to 50 minutes of the study. The second 2021 human clinical study, HYPER-H21-2, has demonstrated up to 23% drop in blood pressure with DehydraTECH-CBD compared with placebo. Though Lexaria still awaits additional analyses, its drug delivery technology has proven useful for potentially treating hypertension. Thirdly, its antiviral program, featuring cell-based and animal studies using Remdesivir and antiviral drugs being investigated for SARS-CoV-2 and HIV/AIDS, has demonstrated enhanced drug delivery. Since it began developing DehydraTECH in 2014, Lexaria has significantly strengthened and broadened the technology to an unprecedented degree. Even so, more may still be in the offing for the company currently disrupting the pharmaceutical industry. For more information, visit the company’s website at www.LexariaBioscience.com. NOTE TO INVESTORS: The latest news and updates relating to LEXX are available in the company’s newsroom at https://ibn.fm/LEXX

• Tryp Therapeutics on September 22 submitted an IND application to the FDA to evaluate its oral formulation of synthetic psilocybin, TRP-8802, in a Phase 2a clinical study
• The study seeks to evaluate TRP-8802 for the treatment of patients with eating disorders and will enroll 10 patients
• According to Tryp Chairman and CEO, the submission is the first of several IND filings the company intends to make in the coming months
• Tryp is also preparing for Phase 2b clinical trials, which will evaluate its proprietary drug candidate, TRP-8803

During a recent investor presentation, Tryp Therapeutics (CSE: TRYP) (OTCQB: TRYPF), a pharmaceutical company focused on developing novel bioscience solutions for conditions with high unmet need, expressed its expectation to initiate at least two Phase 2a clinical trials in Q4 2021 (https://ibn.fm/H85KV). The trials, to be conducted at the University of Florida under the guidance of Dr. Jennifer Miller, a pediatric eating disorders expert and the trials’ principal investigator, will evaluate TRP-8802, Tryp’s oral formulation of synthetic psilocybin, in combination with psychotherapy. The company announced September 22 that it had submitted to the US Food and Drug Administration (“FDA”) an Investigational New Drug (“IND”) application to evaluate TRP-8802 in the Phase 2a study for the treatment of patients with eating disorders (https://ibn.fm/ze4vd), acting as its first major clinical development milestone. According to Dr. Miller, the submission represents hundreds of hours of preparation, design, and coordination as Tryp and its partners “pursue a leading-edge treatment of psilocybin with psychotherapy.” Part of the efforts Dr. Miller was alluding to include collaborations with Clinlogix, a contract research organization (“CRO”), the University of Florida, and Fluence, a psychedelic therapy educational platform. In late August, Fluence undertook and completed the training of psychotherapists who will take part in the trial by overseeing dosing sessions (https://ibn.fm/7G3Ri). On its part, Clinlogix will support the upcoming Phase 2a clinical trials by providing medical writing, biostatistical analysis, data management, and trial monitoring (https://ibn.fm/BP4YW). The submission sets the stage for the Phase 2a clinical trial subject to a favorable review by the FDA. The study is expected to enroll 10 patients with various overeating disorders, such as hypothalamic obesity, binge eating disorder, and Prader-Willi Syndrome. The administration of TRP-8802 is expected to enhance neuroplasticity and help create healthy neural patterns associated with hunger and eating. Prior to the administration, the patients will meet with the trained psychotherapists for two sessions. The psilocybin will then be administered during two drug-dosing sessions, after which integration sessions will follow. “This IND submission marks the most important milestone the company has achieved to date and will be critical in identifying patient responses to the active ingredient, consistent with that of our proprietary drug candidate, TRP-8803, that will be used in Phase 2b trials and beyond,” said Tryp Chairman and CEO Greg McKee. McKee also noted that the submission is the first of several IND filings the company expects to make in the coming months, further reiterating that Tryp is eager to begin enrolling its first patients in multiple Phase 2a trials later this year. For Tryp, this is only the beginning. The company intends to use TRP-8803, its proprietary psilocybin-based drug product manufactured exclusively for Tryp, for Phase 2b clinical trials, and beyond. It has already announced partnerships with the University of Michigan, Calvert Labs, and Gad Consulting to conduct bridging studies in preparation for Phase 2b clinical trials, with more collaborations possibly still in the works. In this regard, the clock has begun counting what will likely be hundreds of additional hours of preparation, design, and coordination in readiness for the Phase 2b trials. For more information, visit the company’s website at www.TrypTherapeutics.com. NOTE TO INVESTORS: The latest news and updates relating to TRYPF are available in the company’s newsroom at https://ibn.fm/TRYPF

• FingerMotion Inc., has become a provider for China’s booming e-commerce market with rich communication services (“RCS”) and big-data insights, developing its Sapientus database as a solution for clients’ predictive services needs
• In addition to its SMS, MMS and mobile top-up business, FingerMotion’s focus on adapting Sapientus to the needs of the insurance industry are driving revenues to new records each quarter
• In China, insurance is compulsory to protect certain societal needs, such as pensions, medical care, employment (and unemployment), and maternity care, creating a ready market for insurance providers
• The Sapientus platform creates proprietary matrices for assessing consumer risk potential using context-based outlooks in accordance with established behaviors

The development of business capabilities to harvest and apply big data insights is affecting revenue streams that vary in size and impact from national government contractors (https://ibn.fm/yE6s6) to farmers harvesting their fields (https://ibn.fm/Vqw3t). Industry e-magazine Datamation reported Sept. 26 on Splunk findings that “organizations with ‘mature data practices’ release twice as many products and increase employee productivity at double the rate of organizations with less mature data practices” (https://ibn.fm/kQuHI). Big data communications technology innovator FingerMotion (OTCQX: FNGR) is focusing its new platform on China’s insurance market as the nation serving as the home to some 1.4 billion people continues to build a powerful economy on the efforts of factories crucial to the global supply chain. FingerMotion launched its Big Data Insights division with its flagship database IP Sapientus last year and attracted global insurance behemoth Pacific Life Re-insurance as a client interested in developing a customer base within China. Sapientus is a stand-out technology that applies publicly available data to clients’ risk forecast needs, generating proprietary matrices that assimilate information on individuals’ behaviors to create context-based outlooks for customers. It’s a service that’s particularly attractive in China since the country’s credit and insurance risk standards are still in a developmental stage and Sapientus can help provide an alternative means of judging potential liabilities for a corporate client. During the past year, FingerMotion’s revenues have seen steady growth, largely due to mobile communications services, and the Pacific Life agreement earlier this year positioned it for an even more promising future.  CEO Martin Shen said during a corporate update conference call discussing the company’s first-quarter financial results in August that FingerMotion’s top-up business had risen 341 percent and mobile SMS and MMS services had increased by 77 percent, and that “some significant funds” raised after the quarter ended will likely lead to a higher outcome on the balance sheet once the Q2 report is completed. “Most of the e-commerce companies operate in the red for quite a while before they turn a profit, but our current trajectory has us moving in that profitable direction a bit quicker than maybe other companies have been,” Shen said (https://ibn.fm/OPdc3). Shen acknowledged that the company has considered eventually focusing its big data platform on other industries beyond insurance and in markets beyond China’s borders, but said the company needs to stay focused on its immediate purpose before expanding its reach. “We’ve always thought of the ability of the algorithms that we have. It’s not really just to perfect those algorithms but it’s also to have them exportable and replicated in other jurisdictions, in other markets. … But again, that takes time to develop, and we’re really still developing what we’re doing right now in China,” Shen said. “Right now, let’s just build and make sure that our foundation is strong first.” For more information, visit the company’s website at www.FingerMotion.com. NOTE TO INVESTORS: The latest news and updates relating to FNGR are available in the company’s newsroom at https://ibn.fm/FNGR

• Some social media platforms, like TikTok, pay artists for their music, but the amounts are insignificant, and an artist’s musical track would have to be used hundreds of thousands of times to make a decent profit
• Friendable’s Fan Pass Live provides artists an online platform to share their music content and earn a profit
• Artists earn on Fan Pass through fan subscriptions, merchandise sales, ticket sales, and more
• Fan Pass artists have access to Pro Services that include logo design and merchandise, as well as social media promotions for upcoming events

2020 was a year of change (and growth) for the music industry. Streaming replaced in-person shows, and artists were forced to adapt and evolve to stake a piece of the revenue. Fast-forwarding to today, live streaming shows and other events are the new normal. More and more artists are entering the virtual stage without representation, simply going online to do what they love and earn money in the process. Artists don’t have to rely solely on social media platforms like TikTok, with revenue structures that constantly change, to gain recognition for their craft. For example, TikTok does pay its artists revenue, but it is based on the number of times their song is used to make a video. Each time the track is used to create a video, it is considered a “creation,” the metric value in which TikTok measures popularity for revenue purposes. To make a living off of TikTok alone, artists would need to secure hundreds of thousands of creations each month (https://ibn.fm/lRrAB). A more attractive and lucrative revenue-generating option available for up-and-coming artists is the Fan Pass platform, launched in July 2020 by Friendable (OTC: FDBL). On the Fan Pass streaming artist platform, artists can build up a fan base, gain access to merchandising, and earn revenue while doing what they love. Each artist has the opportunity to earn revenue from the monthly subscription fee that fans pay to gain access to the Fan Pass artist catalog, merchandise purchases, and even 100% of ticket sales for exclusive live-streamed content and videos on-demand. Artists also have access to premium equipment available for purchase and exclusive Artist Pro Services. The Artist Pro Services are offered in three tiers – basic, standard, and a premium-style option. Each is priced accordingly and offers artists options for logo design, merchandise designs, and marketing material. The process is easy to get started. Artists fill out a form answering survey questions, the prototype is created, and artists then communicate what they like, don’t like, or want to be changed. Packages are even available for social media promotion of upcoming events. Prices range from $45 for a social ad/announcement design to promote the next three events to a $400 pro merch collection with five high-resolution designs placed in the store on any five merchandise items available. Friendable is currently implementing a 120-day plan that strategizes growth for the Fan Pass platform. The company has already accomplished creating and releasing version 2.0 of the platform, gaining acceptance from the Apple Store and Google Play Store for the new application, and launching a brand awareness campaign, among others. Additionally, Fan Pass has begun promoting Pro Services to help artists receive revenue for doing what they love. With this approach and the wealth of services and benefits available, Fan Pass is in a unique position to disrupt the music streaming market, an expanding sector that is growing in value from $20.6 billion in 2019 to an anticipated $60.5 billion by 2026 (marking a CAGR of 16%). The immediate increase for this market segment is due to the increased availability of the internet and access to online content through services like Fan Pass (https://ibn.fm/gw0Vq). For more information, visit the company’s websites at www.Friendable.com or www.FanPassLive.com. NOTE TO INVESTORS: The latest news and updates relating to FDBL are available in the company’s newsroom at http://ibn.fm/FDBL

• FuelPositive recently appointed André Mech as the company’s Strategic Carbon Credit and Emissions Reduction Specialist
• The company also brought Sussex Strategy Group on board to offer government relations services
• So far in 2021, FuelPositive has achieved several milestones, including acquisitions, initial licensing agreements, the commencement of and ultimate completion of phase II build-out
• Going forward, it is building its first systems to be used in demonstration projects in 2022, while it seeks to ramp up production capacity for the 2022 fiscal year

2021, so far, has been an excellent year for FuelPositive (TSX.V: NHHH) (OTCQB: NHHHF). Since holding its first investor presentation back in June 2021, the company has achieved several other milestones and made strategic investments. Combined, these bring it even closer to its ultimate goal of providing sustainable, clean energy to reduce carbon emissions. FuelPositive’s Chief Executive Officer (“CEO”) and Chair of the Board, Ian Clifford, recently appeared on its YouTube channel to highlight the company’s recent developments and offer insights into its future (https://ibn.fm/q6gNg). Of note was the move to bring on board André Mech, who would assume the position of Strategic Carbon Credit and Emissions Reduction Specialist. Focusing on carbon-free ammonia is a lucrative move by FuelPositive, allowing it to monetize carbon credits by selling them through different exchanges around the world (https://ibn.fm/RDzdM). Mr. Clifford, however, has acknowledged that this is a complicated process that requires someone who knows how to approach and effectively deal with it. With his years of experience, Mech would help the company navigate the industry and achieve this goal. He would be lending his years of experience from advising governments and organizations on sustainability, energy efficiency, and carbon reduction, thereby helping FuelPositive sell its carbon credits in the same way that Tesla does. Mr. Clifford also touched on hiring Sussex Strategy Group to offer government services. Like André Mech, this organization would help FuelPositive navigate the government landscape, securing partnerships and funding for projects that will prove FuelPositive’s technology and ultimately help governments achieve, or even surpass the promises of the Paris Agreement (https://ibn.fm/wr1gO). To date, FuelPositive has managed to achieve three main milestones for the 2021 fiscal year: process determination, primary component vendor selection and procurement, and engineering design. These milestones touch on most of the company’s activities, including but not limited to major component design, the fabrication of reactors, and ammonia separation modeling and design (https://ibn.fm/OAK7F). The company has also made some notable acquisitions and begun the build-out of Phase II systems (https://ibn.fm/DMbXC). Going forward into 2022, the company plans to put systems in place for demonstration projects with partners and ramp up production capability in the early half of the year, and start shipping commercial systems in the last quarter of 2022. The hydrogen economy is at the core of FuelPositive’s agenda. Through its carbon-free ammonia, the company offers a solution that requires 30% less energy than conventional ammonia production, with zero carbon emissions. FuelPositive can also store 65% more hydrogen in its carbon-free NH3 than traditionally highly compressed hydrogen, making hydrogen easy to store and transport using existing infrastructure, and differentiating the company from its competitors (https://ibn.fm/K63kr). The global green ammonia market size is projected to post a 54% year-over-year growth between 2020 and 2025 (https://ibn.fm/rZb92). With FuelPositive spearheading the modular and scalable carbon-free ammonia industry, the company plans to bank on the opportunities therein and be part of this imminent growth. So far, the company’s systems and infrastructure place it in a great position to achieve this and other target milestones set for the coming financial year, something that Mr. Clifford has expressed optimism and enthusiasm for. FuelPositive believes that carbon-free ammonia is the future. All strategic decisions made in 2021 have taken the company steps closer to realizing a world with sustainable, clean energy that replaces fossil fuels. The company’s future looks bright, and its role in pushing for the change from fossil fuels cannot be ignored. For more information, visit the company’s website at www.FuelPositive.com. NOTE TO INVESTORS: The latest news and updates relating to NHHHF are available in the company’s newsroom at https://ibn.fm/NHHHF

• Ideanomics has entered into an agreement with the founders of Energica, embodying plans to increase its stake to 70%
• The renewed investment interest further extends IDEX’s resolve to expand its global footprint in the EV industry
• Energica is the manufacturer of high-performance all-electric motorcycles
• Ideanomics will participate at the upcoming MOVE America event, scheduled for September 28-30, where it will showcase technologies from WAVE and Energica

Ideanomics (NASDAQ: IDEX), a global company that facilitates the adoption of commercial electric vehicles (“EVs”) and supports next-generation financial services and fintech products, announced September 15 that it has entered into an agreement to launch a voluntary conditional tender offer together with the founders of Energica Motor Company S.p.A (“Energica”). The offer will see IDEX increase its stake to 70%, while the founders shall continue to own 29% of the Italy-based company, subject to regulatory approval and other closing conditions (https://ibn.fm/fzYmb). The recent announcement comes about six months after Ideanomics acquired a 20% stake in Energica, a manufacturer and distributor of high-performance 100% battery-powered motorbikes (https://ibn.fm/CSgsH). At the time, the investment represented IDEX’s resolve to expand its global footprint in the EV industry and complemented Treeletrik’s operations in the ASEAN market. Ideanomics purchased a controlling stake in the sales and distribution arm of Treeletrik, a Malaysia-based manufacturer of all-electric motorcycles, in March 2019 (https://ibn.fm/L6Ki2). The renewed investment interest, as captured by the recent agreement, therefore extends this resolve even further. “We are grateful for Energica’s continued interest in growing synergistically alongside other brands within the Ideanomics Mobility ecosystem,” commented Ideanomics CEO Alf Poor (https://ibn.fm/poF0l). “With exceptional management and leadership in place and a full range of innovative zero-emissions products already in the market, we believe Energica has the opportunity to benefit strongly from Ideanomics Capital’s resources, transforming their growth trajectory and positioning them as a global leader in the electric motorcycle market.” Manufactured in historic Modena, the heart of the Italian Motor Valley, Energica motorcycles are the ultimate embodiment of the Italian design, performance, and exclusivity. Thanks to their state-of-the-art, race-derived technology, they boast the highest emissions-free peak and sustained performance of any road-legal electric motorcycle. It is no wonder that they have been a hit among motorcycle enthusiasts, as seen through Energica’s sales statistics. In 2020, the company nearly doubled its sales, while 2021 has seen the manufacturer accept its largest order to date. This growth trajectory may continue well into the future, especially in the wake of a Technavio market research report, which anticipates that the high-performance electric motorcycle market will grow at a CAGR of more than 35% between 2020 and 2024, with Europe accounting for about 39% of the overall growth (https://ibn.fm/VcVtH). “The two-wheeler electric market is poised for significant growth, and we couldn’t be more excited about the synergies between Ideanomics and Energica that will allow us to be a prime player in this space,” said Ideanomics’ Executive Chairman, Shane McMahon. Part of these synergies will be on display at an upcoming global showcase event for urban mobility discussions and solutions, MOVE America, in which Ideanomics will be a participant (https://ibn.fm/CUI2A). Ideanomics will showcase technologies from WAVE, a wireless charging provider allowing commercial fleet operators to extend the range of medium- and heavy-duty EVs with 125kW to 500kW charging systems, and Energica. The event will be held from September 28 to 30 at the Palmer Events Center in Austin, Texas. On September 28 at 10.40 am CT, WAVE CEO Aaron Gillmore will give a keynote presentation about overcoming fleet electrification barriers with wireless charging for the bus transportation sector. Later in the day, at 1:00 pm, he, in concert with Kate Lam, Ideanomics’ Managing Director of Financial Products, will lead a roundtable discussion on fleet electrification challenges. Thereafter at 2:55 pm, WAVE CTO Michael Masquelier will participate in a Truck Tech Panel. “MOVE is an opportunity for Ideanomics and our operating companies like Energica and WAVE to talk more about the things we are doing in the fleet electrification space that matter,” said Alf. For more information, visit the company’s website at www.Ideanomics.com. NOTE TO INVESTORS: The latest news and updates relating to IDEX are available in the company’s newsroom at https://ibn.fm/IDEX

• DigiMax now has $18 million in growth financing, including investment from H.C. Wainwright
• The company has expanded product offerings scheduled for launch throughout the second half of 2021
• DigiMax has plans to acquire strategic technologies to spur further growth
• The company has an expert AI team in place
• The AI industry has a five-year CAGR of 18.4%, with revenues projected to reach $37.9 billion by 2024

DigiMax Global (CSE: DIGI) (OTC: DBKSF) is an artificial intelligence technology and services company producing and leveraging predictive indicators across various industries and verticals. The company offers financial, business, and human capital AI predictive solutions to businesses, institutions, and consumers to improve decision-making. The DigiMax core solutions are:

1. CryptoHawk AI – CryptoHawk is a deep learning AI solution (“SaaS”) that monitors and analyzes live select cryptocurrencies and financial markets. The CryptoHawk AI solution is offered to retail clients as a monthly subscription. Generated data provides subscribers with price trend predictions for better investment strategies.
2. Cryptocurrency Hedge Fund – A long/short cryptocurrency hedge fund for high net worth, institutional, and family office clients was launched on September 1, 2021. The company’s crypto hedge fund earns clients’ management and overall performance fees.
3. Projected Personality Interpreter (“PPI”) – DigiMax solutions utilize AI to provide comparative insights for better hiring decisions, reduced employment attrition, improved workplace culture, and augmented human and financial predictive services by measuring and correlating personal attributes.
4. Navee Predict – DigiMax data scientists provide companies with the unprecedented power of enhancing decision-making by analyzing, detecting changes and forecasting patterns.

The company’s team has extensive experience in finance, trading, machine learning (“ML”), neural language processing, AI, big data, and cryptocurrency technology. DigiMax leverages AI and its expert team to translate data into actionable predictive insights across the financial, business, and human dimensions, enhancing the decision-making capacity of organizations. DigiMax is an official IBM Watson partner with more than 30 years in data science and artificial intelligence. Solutions Business and Financial Capital Solutions CryptoHawk AI CryptoHawk.ai is a cryptocurrency price and trend prediction solution offered as a web application (https://cryptohawk.ai) and a mobile application by the end of 2021. The value for the user is to capture gains and take advantage of volatility while reducing risk and engaging in smarter and simpler trading. The key features:

• Trend Prediction Indicator (“TPI”) The TPI is a superior model that leverages the cryptocurrencies analyzed by the AI and other market-driven data and policies to produce actionable predictions in the form of:

• Prediction cards
• Cryptocurrency graphs with optional market indicators
• Email/SMS alerts
• Trend Watch Trend Watch is a one-week look ahead machine learning prediction for a select portfolio of mature cryptocurrencies. Trend Watch predicts a trend being UP or DOWN and provides a price target. Users have access to:
  • A list of select cryptocurrencies with predictive graphs

The system alerts investors through email and text messages when a price trend changes, allowing users to act confidently. Cryptocurrency Hedge Fund On September 1, 2021, DigiMax launched its Cryptocurrency Hedge Fund to offer high net worth, institutional, and family office clients a fully systematic long/short active investment into a basket of cryptocurrencies capitalizing on crypto volatility and powered by proprietary trading algorithms. The official launch is expected in the coming months. The fund is led by 40-year hedge fund veteran Ian Hamilton and has an experienced investment and fund management team. This actively managed fund provides an excellent opportunity for larger investors to gain exposure to cryptocurrencies. AI Business Prediction as a Service The company offers predictive insights to businesses through automation and its innovative and proprietary AI and ML technology. Traditional models are expensive, because they are created and developed by data scientists dedicated to solving specific business questions that require costly customization and weeks, if not months, of development. With DigiMax, companies have access to solutions and services at a fraction of the price of traditional and experimental approaches. By combining AI with ML prediction technology, the company delivers insights on:

• Sales forecasts
• Optimal inventory levels
• Supply chain management
• Invoice payment projections
• Targeted segmentation for marketing campaigns

Human Capital Solutions AI-Powered Projected Personality Interpreter The Projected Personality Interpreter (“PPI”) evaluates and improves customers’ workforce, brand and culture by revealing the personality traits and sentiment buried in human expression. The PPI empowers organizations with comparative insight for better hiring decisions, reducing employment attrition and improving workplace culture. PPI provides a comprehensive and complete solution, offering:

• Recruitment campaign management
• Custom questionnaires, desirable traits recipes, and group likenesses
• Detailed personality reports to compare and contrast peers
• API for advanced integration with alternative systems of record

DigiMax leverages IBM Watson and a custom algorithm that analyzes applicant responses across 52 different traits and compares those scores with a baseline, providing hiring managers with a comprehensive report that improves decision making and takes the bias out of the process. The company’s solution is currently in use by 17 law enforcement agencies in North America and is used across the 10 global recruitment brands of Shepherd Search Group. Market Overview The AI industry has a five-year CAGR of 18.4%, with revenues projected to reach $37.9 billion by 2024. Some more optimistic forecasts have the market worth as much as $15 trillion by 2030. It’s estimated that 80% of all emerging technologies in 2021 have AI foundations. About 40% of all businesses use AI in their operations. According to Industry Ark, artificial intelligence use in the recruitment market was valued at $580 million in 2019. Management Team Chris Carl, CEO Chris Carl has over 20 years of experience as a public-company CEO and has built several successful businesses across multiple categories. He has a proven ability to lead and has a track record of execution, revenue growth, and value creation. Thierry Hubert, CTO Thierry Hubert has 30 years of technology experience with Fortune 100 companies worldwide and is an early pioneer in applying artificial intelligence to solve big data and unstructured information challenges with IBM as a Director of R&D in emerging technology, knowledge management, and process innovation. He has received awards, recognitions, and grants that contributed to his ongoing collaboration with industry leaders. David Bhumgara, CFO David Bhumgara is a senior finance executive with over 25 years of leadership experience and proven expertise in finance, financial reporting, accounting, corporate finance, budgeting, financial modeling, and mergers & acquisitions. Damon Stone, Trading Strategy Advisor Damon Stone is an experienced stock and crypto trader who works very closely with the Cryptodivine.ai data science team as a subject matter expert. During 15 years at Merrill Lynch as a market maker and proprietary trader, he traded many different sectors, culminating in heading up a $250 million trading desk. Ross Power, Senior Innovation Engineer Ross Power is an experienced technical system architect with a demonstrated history of working on advanced technologies, including AI algorithms, IoT solutions, 3D printing, Innovation in BCI (Brain-Computer Interfacing), and RC flight and navigation systems. For more information, visit the company’s website at https://digimaxglobal.com. NOTE TO INVESTORS: The latest news and updates relating to DBKSF are available in the company’s newsroom at https://ibn.fm/DBKSF

• BevCanna Enterprises Inc. is a diversified health & wellness beverage and natural products company, which offers in-house brands and provides white-label production and distribution solutions to its industry-leading partners
• BevCanna has recently announced tie-ups with Keef Brands as well as with The Tinley Beverage Company to produce and distribute their products within the Canadian continent

Functional drinks and drinks based on plant derivatives — particularly those containing cannabis- or hemp-derived ingredients like cannabidiol (“CBD”) or tetrahydrocannabinol (“THC”) — have rapidly established themselves as one of the fastest-growing verticals within the North American beverage industry, with a recent study forecasting the global cannabis drinks sector to triple in value to $5.8 billion by 2024. BevCanna Enterprises (CSE: BEV) (OTCQB: BVNNF) (FSE: 7BC), a diversified health & wellness beverage and natural products company developing and manufacturing a range of alkaline, plant-based and cannabinoid beverages and supplements for both in-house brands and white-label clients has sought to capitalize on the growing demand, most recently through its various collaborations with US cannabis-infused beverage manufacturers (https://ibn.fm/QaNnN). Surveys have shown that in U.S. states where cannabis is legal for recreational use, drinks make up 15 percent of purchased cannabis value, with one in four consumers remarking that they would be willing to try cannabis-infused drinks.  The strong growth trends witnessed in the U.S look particularly promising for the nascent Canadian cannabis-derived drinks market, with the sector poised for significant growth in the coming months and years. A key growth driver set to underpin future growth within the Canadian cannabis beverage market lays within the product selection currently available within the sector. BevCanna have sought to widen selection through the introduction of several leading US brands within the Canadian domestic market, capitalizing on their existing manufacturing facilities and nationwide distribution coverage.  In early August, BevCanna announced that they had successfully completed the first commercial production run of the leading U.S. beverage brand, Keef Brands’ cannabis-infused beverages, for delivery to select provincial distribution boards across Canada. “This inaugural run of Keef represents a significant milestone for BevCanna,” said Melise Panetta, president of BevCanna (https://ibn.fm/ADWHv). “We’re launching in multiple Canadian markets and are excited to be including this already well-known and loved cannabis brand among our first offerings. We expect that Keef will take a leadership position within the Canadian cannabis-infused beverage space” The company also announced on August 19 that it had signed a definitive agreement with The Tinley Beverage Company Inc. (CSE: TNY) (OTCQX: TNYBF) to co-manufacture its award-winning cannabis-infused beverages for the Canadian market. The agreement will see BevCanna produce and distribute Tinley’s full product portfolio which includes their line of ready-to-drink, adult beverage-inspired sparkling Tinley Classics, Tinley’s Tonics as well as their Moscow Mule-inspired Tinley’s Tonics High Horse, among various others. With U.S. beverage makers increasingly seeking to venture into Canada’s relatively under-penetrated cannabis beverage market, BevCanna’s white-label partnership model for Canadian production and distribution allows the company’s potential non-licensed partners to mark their initial forays into the Canadian cannabis market in a smooth and compliant manner. In addition, BevCanna’s broad distribution network, which features over 3,000 points of retail distribution spread across Canada, allows for companies to dramatically expand their retail footprint while subject to a single, seamless partnership. For more information, visit the company’s website at www.BevCanna.com. NOTE TO INVESTORS: The latest news and updates relating to BVNNF are available in the company’s newsroom at http://ibn.fm/BVNNF